Sophie Cole

Sophie Cole

Auto-generated profile, based on publicly available information

Sophie Cole

Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
SCSophie Cole
Sophie Cole
SKSpyros Kolovos
Spyros Kolovos
AIAnushka Irani
Anushka Irani
ADAntonella Delmestri
Antonella Delmestri
MSMaria T Sanchez-Santos
Maria T Sanchez-Santos
RPRafael Pinedo-Villanueva
Rafael Pinedo-Villanueva
Objective As part of the STAR Programme, a comprehensive study exploring long-term pain after surgery, we investigated how pain and function, health-related quality of life (HRQL), and healthcare resource use evolved over 5 years after total knee replacement (TKR) for those with and without chronic pain 1 year after their primary surgery. Methods We used data from the Clinical Outcomes in Arthroplasty Study prospective cohort study, which followed patients undergoing TKR from two English hospitals for 5 years. Chronic pain was defined using the Oxford Knee Score Pain Subscale (OKS-PS) where participants reporting a score of 14 or lower were classified as having chronic pain 1-year postsurgery. Pain and function were measured with the OKS, HRQL using the EuroQoL-5 Dimension, resource use from yearly questionnaires, and costs estimated from a healthcare system perspective. We analysed the changes in OKS-PS, HRQL and resource use over a 5-year follow-up period. Multiple imputation accounted for missing data. Results Chronic pain was reported in 70/552 operated knees (12.7%) 1 year after surgery. The chronic pain group had worse pain, function and HRQL presurgery and postsurgery than the non-chronic pain group. Those without chronic pain markedly improved right after surgery, then plateaued. Those with chronic pain improved slowly but steadily. Participants with chronic pain reported greater healthcare resource use and costs than those without, especially 1 year after surgery, and mostly from hospital readmissions. 64.7% of those in chronic pain recovered during the following 4 years, while 30.9% fluctuated in and out of chronic pain. Conclusion Although TKR is often highly beneficial, some patients experienced chronic pain postsurgery. Although many fluctuated in their pain levels and most recovered over time, identifying people most likely to have chronic pain and supporting their recovery would benefit patients and healthcare systems.

22 January 2025 in Health Policy
Verified
Journal Article
Open access
ZAZachary Dv Abel
Zachary Dv Abel
Laurence RoopeLaurence Roope
Laurence Roope
RDRaymond Duch
Raymond Duch
SCSophie Cole
Sophie Cole
PCPhilip M Clarke
Philip M Clarke
Background COVID-19 vaccine hesitancy was a key barrier to ending the pandemic via mass immunisation. Objectives Assess magnitudes and differences in socioeconomic inequality in stated COVID-19 vaccine acceptance (hesitancy) and uptake. Methods Online surveys were conducted in 13 countries, collecting data from 15,337 and 18,189 respondents respectively. The investigation compares socioeconomic inequality in reported vaccine acceptance, measured in 2020-21 and subsequent uptake of vaccination in 2022. Inequalities are quantified using differences, ratios and the Erreygers adjusted concentration index. A regression decomposition approach is used to identify factors associated with inequality. Results Mean uptake levels were 87 %, while acceptance was lower at 77 %. The difference between the richest and the poorest quintile was as large as 23 percentage points in acceptance and 30 p.p. in uptake, both observed in France. Acceptance and uptake were pro-rich (regressive) in most countries. Nine countries reported pro-rich inequality in acceptance, and eight in uptake. Uptake was significantly less regressive than acceptance in Australia, China, India, and USA. Australia and Colombia were the only countries where vaccination uptake was pro-poor (progressive). Age, marital status and political ideology were correlated with socioeconomic inequalities in several countries in both waves, while gender and education were associated with acceptance, and health levels with uptake. Conclusion We found significant inequalities in vaccination acceptance and uptake across countries but inequality was generally lower in vaccine uptake than in acceptance. This suggests that inequalities can be reduced over time if adequate policies are in place to overcome hesitancy and reduce inequalities.

29 September 2026 in International Journal for Equity in Health
Verified
Journal Article
Open access
PDF file
ZAZachary D. V. Abel
Zachary D. V. Abel
SCSophie Cole
Sophie Cole
Guido ErreygersGuido Erreygers
Guido Erreygers
Laurence RoopeLaurence Roope
Laurence Roope
PCPhilip M. Clarke
Philip M. Clarke
Background: Randomised trials seldom investigate the impacts interventions have on socioeconomic inequality in health, focusing instead on their average treatment effects. Methods: We illustrate how standard measures of inequality such as the corrected concentration index can be reported in randomised experiments to quantify the interventions’ socio-economic distribution effect alongside more traditional average treatment effects. We illustrate this with a proof-of-concept example using a study on the impact of information and financial incentives on verified COVID-19 vaccination uptake in rural Ghana ( n = 2,271). We estimate the distributional treatment effects of informational public health messaging, low- and high-cash financial incentives relative to a placebo group and present this information on an achievement plane. Results: Health messaging had a pro-rich socioeconomic inequality impact of -0.132 [95% CI: -0.28–0.02] relative to the placebo group, while the low and high cash incentives had impacts of -0.108 [95% CI: -0.29–0.07] and − 0.081 [95% CI: -0.26–0.11] respectively, providing no significant evidence for changes in inequality relative to the placebo group. A low-cash incentive was the only intervention that was shown to increase vaccination uptake. Conclusions: A socioeconomic inequality of health distributional indicator could routinely be calculated in experimental results and presented alongside average treatment effects. This would enable the identification of whether there are equality-efficiency trade-offs. The methods presented in this paper can be used to support policy decision making with representative datasets provided there is appropriate statistical power. Trial registration: The RCT investigated in this paper was registered with the American Economic Association on January 10, 2022, RCT ID: AEARCTR-0008775.

6 October 2022 in Research Square
Verified
Preprint
Open access
PDF file
SCSophie Cole
Sophie Cole
MSMaria T. Sanchez-Santos
Maria T. Sanchez-Santos
SKSpyros Kolovos
Spyros Kolovos
MJM. Kassim Javaid
M. Kassim Javaid
RPRafael Pinedo-Villanueva
Rafael Pinedo-Villanueva
Background X-linked hypophosphataemia (XLH) is a rare genetic condition passed on through the X chromosome which causes multiple symptoms including weakened teeth, bones, and muscles. Due to the rarity of the condition, little is known about the health outcomes as reported by people with the disease. The objectives of this study were threefold: to characterise key patient reported outcome measures (PROMs) in adults with XLH, to identify clusters of symptom-severity groups based on PROMs, and to analyse the longitudinal progression of available PROMs. Methods Data from 48 participants from the Rare and Undiagnosed Diseases cohort Study (RUDY) was used to analyse both cross-sectional and longitudinal patient-reported outcomes. We analysed data for health-related quality of life (HRQL): EQ-5D-5L, SF-36 Physical Component Score (PCS), and SF-36 Mental Component Score (MCS), sleep: PSQI and ESS, fatigue: FSS and FACIT-F, pain: SF-MPQ-2 and PainDETECT, and mental well-being: HADS anxiety and depression. Summary statistics, tests of mean differences, mixed-effects models, and cluster analysis were used to describe and examine the various health dimensions of individuals with XLH. Results Overall mean scores were EQ-5D-5L=0.65, SF-36-PCS=32.7, and SF-36-MCS=48.4 for HRQL, ESS=5.9 and PSQI=8.9 for sleep, FSS=32.8 and FACIT-F=104.4 for fatigue, SF-MPQ-2=1.9, and 7% reporting neuropathic pain (PainDETECT) for pain, and HADS-depression=4.7 and HADS-anxiety =6.2 for mental well-being. 7% reported neuropathic pain (PainDETECT) for pain. Whilst many adults with XLH reported good outcomes, extreme or severe problems were reported across all outcomes. Cluster analysis identified that adults with XLH could be divided into two distinct groups, one reporting worse (35.3%) and the other better outcomes (64.7%) (less pain, fatigue, depression, and higher levels of sleep). Longitudinal analysis showed that FACIT-F and HADS-anxiety scores worsened slightly over two years with statistically significant (p<0.05) time coefficients (b=-2.135 and b=0.314, respectively). Conclusion Although about two thirds of adult participants of the RUDY cohort with XLH report good health outcomes, for a considerable third much worse outcomes are reported. More research is needed to examine why some experience good and others poor health outcomes and the characteristics which identify them.